199 related articles for article (PubMed ID: 25501281)
1. Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes.
Sadeghi RN; Karami-Tehrani F; Salami S
Tumour Biol; 2015 Apr; 36(4):2893-905. PubMed ID: 25501281
[TBL] [Abstract][Full Text] [Related]
2. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
Aghaei M; Karami-Tehrani F; Panjehpour M; Salami S; Fallahian F
Prostate; 2012 Mar; 72(4):361-75. PubMed ID: 21656837
[TBL] [Abstract][Full Text] [Related]
3. NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Hu J; Lei H; Fei X; Liang S; Xu H; Qin D; Wang Y; Wu Y; Li B
Sci Rep; 2015 Nov; 5():17426. PubMed ID: 26616394
[TBL] [Abstract][Full Text] [Related]
4. CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation.
Itkonen HM; Poulose N; Walker S; Mills IG
Neoplasia; 2019 Jul; 21(7):713-720. PubMed ID: 31151054
[TBL] [Abstract][Full Text] [Related]
5. Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin.
Kong JY; Rabkin SW
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H717-25. PubMed ID: 11788422
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.
Aghaei M; Panjehpour M; Karami-Tehrani F; Salami S
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1511-23. PubMed ID: 21830157
[TBL] [Abstract][Full Text] [Related]
7. Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell.
Pan B; Zheng S; Liu C; Xu Y
Mol Biol Rep; 2013 Jan; 40(1):27-33. PubMed ID: 23117283
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis.
Liou SF; Lin HH; Liang JC; Chen IJ; Yeh JL
Toxicology; 2009 Feb; 256(1-2):13-24. PubMed ID: 19056458
[TBL] [Abstract][Full Text] [Related]
9. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.
Schlaepfer IR; Rider L; Rodrigues LU; Gijón MA; Pac CT; Romero L; Cimic A; Sirintrapun SJ; Glodé LM; Eckel RH; Cramer SD
Mol Cancer Ther; 2014 Oct; 13(10):2361-71. PubMed ID: 25122071
[TBL] [Abstract][Full Text] [Related]
10. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway.
Lee J; Lee S; Kim SL; Choi JW; Seo JY; Choi DJ; Park YI
Life Sci; 2014 Dec; 119(1-2):47-55. PubMed ID: 25445226
[TBL] [Abstract][Full Text] [Related]
11. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.
Valentino A; Calarco A; Di Salle A; Finicelli M; Crispi S; Calogero RA; Riccardo F; Sciarra A; Gentilucci A; Galderisi U; Margarucci S; Peluso G
Oncogene; 2017 Oct; 36(43):6030-6040. PubMed ID: 28671672
[TBL] [Abstract][Full Text] [Related]
13. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
Szliszka E; Helewski KJ; Mizgala E; Krol W
Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
[TBL] [Abstract][Full Text] [Related]
14. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
[TBL] [Abstract][Full Text] [Related]
15. Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.
Peng Q; Zhou J; Zhou Q; Pan F; Zhong D; Liang H
Hepatogastroenterology; 2009; 56(90):355-60. PubMed ID: 19579598
[TBL] [Abstract][Full Text] [Related]
16. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
17. Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
Wang L; Liu C; Li C; Xue J; Zhao S; Zhan P; Lin Y; Zhang P; Jiang A; Chen W
Gene; 2015 Nov; 572(2):252-8. PubMed ID: 26164758
[TBL] [Abstract][Full Text] [Related]
18. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
19. Eupalitin induces apoptosis in prostate carcinoma cells through ROS generation and increase of caspase-3 activity.
Kaleem S; Siddiqui S; Siddiqui HH; Badruddeen ; Hussain A; Arshad M; Akhtar J; Rizvi A
Cell Biol Int; 2016 Feb; 40(2):196-203. PubMed ID: 26493029
[TBL] [Abstract][Full Text] [Related]
20. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
